These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20138186)

  • 1. Immunodominance analysis through interactions of CD8+ T cells and DCs in lymph nodes.
    Wu YU; Xia L; Zhang M; Zhao X
    Math Biosci; 2010 May; 225(1):53-8. PubMed ID: 20138186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes.
    Skokos D; Shakhar G; Varma R; Waite JC; Cameron TO; Lindquist RL; Schwickert T; Nussenzweig MC; Dustin ML
    Nat Immunol; 2007 Aug; 8(8):835-44. PubMed ID: 17632517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes.
    Bousso P; Robey E
    Nat Immunol; 2003 Jun; 4(6):579-85. PubMed ID: 12730692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutual helper effect in copulsing of dendritic cells with 2 antigens: a novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously.
    Shojaeian J; Jeddi-Tehrani M; Dokouhaki P; Mahmoudi AR; Ghods R; Bozorgmehr M; Nikoo S; Bayat AA; Akhondi MM; Ostadkarampour M; Rezania S; Zarnani AH
    J Immunother; 2009 May; 32(4):325-32. PubMed ID: 19342973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avidity of CD8 T cells sharpens immunodominance.
    Dzutsev AH; Belyakov IM; Isakov DV; Margulies DH; Berzofsky JA
    Int Immunol; 2007 Apr; 19(4):497-507. PubMed ID: 17376783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
    Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
    Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.
    Jenne L; Arrighi JF; Jonuleit H; Saurat JH; Hauser C
    Cancer Res; 2000 Aug; 60(16):4446-52. PubMed ID: 10969791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.
    Tsang KY; Zhu M; Even J; Gulley J; Arlen P; Schlom J
    Cancer Res; 2001 Oct; 61(20):7568-76. PubMed ID: 11606396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model.
    Gapin L; Bravo de Alba Y; Casrouge A; Cabaniols JP; Kourilsky P; Kanellopoulos J
    J Immunol; 1998 Feb; 160(4):1555-64. PubMed ID: 9469410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S; Yuan J; Xiang J
    J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell-based cancer vaccines.
    Chen W; McCluskey J
    Adv Cancer Res; 2006; 95():203-47. PubMed ID: 16860659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity.
    Hugues S; Fetler L; Bonifaz L; Helft J; Amblard F; Amigorena S
    Nat Immunol; 2004 Dec; 5(12):1235-42. PubMed ID: 15516925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers.
    Bohnenkamp HR; Coleman J; Burchell JM; Taylor-Papadimitriou J; Noll T
    Cell Immunol; 2004; 231(1-2):112-25. PubMed ID: 15919376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content.
    Vuylsteke RJ; Molenkamp BG; van Leeuwen PA; Meijer S; Wijnands PG; Haanen JB; Scheper RJ; de Gruijl TD
    Clin Cancer Res; 2006 May; 12(9):2826-33. PubMed ID: 16675577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
    Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P
    Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vgamma9gammadelta T cell activation.
    Takahara M; Miyai M; Tomiyama M; Mutou M; Nicol AJ; Nieda M
    J Leukoc Biol; 2008 Mar; 83(3):742-54. PubMed ID: 18156189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene.
    Pérez-Díez A; Butterfield LH; Li L; Chakraborty NG; Economou JS; Mukherji B
    Cancer Res; 1998 Dec; 58(23):5305-9. PubMed ID: 9850054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity.
    Carbone FR; Belz GT; Heath WR
    Trends Immunol; 2004 Dec; 25(12):655-8. PubMed ID: 15530835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.